Product approval information for use in adults 18 through 65 years of age as immunotherapy for house dust mite- (HDM)-induced allergic rhinitis, with or without conjunctivitis, confirmed by in vitro testing for IgE antibodies to Dermatophagoides farinae or Dermatophagoides pteronyssinus house dust m
Recommend0 recommendationsPublished in US National Health Agency Sources
A Martian dust devil can be seen consuming a smaller one in this short video made of images taken by a navigation camera aboard NASA’s…
More than 10 years ago, Arizonans voted to approve the implementation of the Arizona Medical Marijuana Program. In 2020, the program expanded with the passing of Prop 207, allowing for the adult recreational use of marijuana. There are now many dispensaries and adult-use facilities statewide, where adults above the age of 21 can purchase marijuana […]
Before the first case of influenza was reported in the Flagstaff area this fall, public health researchers from ADHS and Coconino County Health and Human Services already knew it was coming. How? By testing wastewater for signs of influenza. Wastewater surveillance for signs of specific diseases is a new and growing tool for public health […]
The U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorizations (EUA) for monoclonal antibodies to treat COVID-19 for certain patients. Clinicians will learn the FDA’s role in issuing EUAs for certain monoclonal antibodies, options for compassionate use, the process for ordering and distributing monoclonal antibodies, and current data on using monoclonal antibodies for both non-hospitalized and immunocompromised patients. Presenters will also cover preventing, diagnosing, and treating COVID-19 in immunocompromised patients, including the role of monoclonal antibodies, serologic testing, and potential third dose of COVID-19 vaccinations.
This video can also be viewed at
https://emergency.cdc.gov/coca/wmv/2021/081221_video.mp4
October 15, 2022 is National Latinx Aids Awareness Day (NLAAD). This observance calls for raising awareness on the impact of HIV on Hispanic/Latino/Latinx communities and eliminating stigma. NLAAD, first created by the by the Hispanic Federation and the Latino Commission on AIDS in 2003, is a good opportunity to feature the CDC’s Let’s Stop HIV Together …
The post Recognizing National Latinx Aids Awareness Day appeared first on Salud America.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
